(Reuters) - Medtronic Plc has agreed to stop manufacturing and distributing its SynchroMed implantable drug pump, U.S. regulators said on Monday, a step toward resolving allegations that the company ...
Medtronic has received FDA clearance for a new implantable pain management device that can be programmed wirelessly via a Samsung tablet. The Intellis system is designed to treat chronic pain by ...
Medtronic’s SynchroMed II implantable drug pump device, which has been recalled three times in recent years and tied to 14 deaths, has continued to be problematic for the medtech company. A three-page ...
Medtronic has issued an urgent medical device correction on its SynchroMed II implantable drug infusion pumps, warning that the batteries in certain devices might suddenly fail, according to a news ...
CHICAGO (Reuters) - Medtronic Inc has sent a letter to physicians warning about possible reduced battery performance in a small percentage of its SynchroMed II Implantable Drug Infusion Pumps, the ...